An economical approach to surveying the human kinome, scanEDGE includes 97 kinases distributed throughout the AGC, CAMK, CMGC, CK1, STE, TK, TKL, lipid, and atypical kinase families, plus important mutant forms. scanEDGE is an economical alternative to scanMAX and useful to assess compound selectivity at all stages of drug discovery and development, from lead discovery & hit identification to lead optimization.
Panel Features & Benefits
- Panel of 97 kinases distributed across the kinome
- High-quality reproducible data
- Rapid turnaround time
- Broad dynamic range: detect compounds with Kds <100 pm to >10 uM
- Flexible – standard and custom panels
- Detection of multiple inhibitor types (e.g. type I, II & non-ATP competitive)
- Economically priced
